(Q40627561)

reason for preferred rank

22 September 2017

title

LysB3, GluB29 insulin: a novel insulin analog with enhanced β-cell protective action (English)

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

20 March 2024

LysB3, GluB29 insulin: a novel insulin analog with enhanced beta-cell protective action (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550282

20 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

20 March 2024

3

Jürgen Eckel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550282

20 March 2024

author name string

Irini Rakatzi

1

1 reference

22 September 2017

Gerhard Seipke

2

1 reference

22 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14550282

20 March 2024

publication date

1 October 2003

1 reference

22 September 2017

24 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14550282

full work available at URL

20 March 2024

https://api.elsevier.com/content/article/PII:S0006291X03018941?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

https://api.elsevier.com/content/article/PII:S0006291X03018941?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Biochemical and Biophysical Research Communications

20 March 2024

published in

1 reference

22 September 2017

volume

310

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

852-859

1 reference

Molecular insights into insulin action and secretion

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Autoimmunity and diabetes

20 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus

20 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Role of apoptosis in pancreatic beta-cell death in diabetes

20 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

beta-cell apoptosis: stimuli and signaling

20 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Apoptosis and the pathogenesis of IDDM: a question of life and death

20 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus

20 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

20 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.

20 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression

20 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover

20 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis

20 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells

20 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Ceramide activates NFkappaB by inducing the processing of p105.

20 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Control of cell survival by IGF signaling pathways.

20 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis

20 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis: involvement of phosphatidylinositol 3-kinase.

20 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice

20 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1).

20 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation

20 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

IRS proteins and beta-cell function

20 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1.

20 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

20 March 2024

Caspases: enemies within

24

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Morphological and biochemical characterization and analysis of apoptosis

20 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.

20 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

A search for tyrosine kinase receptors expressed in the rat embryonic pancreas.

20 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Insulin receptor-deficient cells as a new tool for dissecting complex interplay in insulin and insulin-like growth factors.

20 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells

20 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

20 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Disruption of IRS-2 causes type 2 diabetes in mice

20 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.

20 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth.

20 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells

20 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Insulin-like growth factor-I-induced DNA synthesis in insulin-secreting cell line RINm5F is associated with phosphorylation of the insulin-like growth factor-I receptor and the insulin receptor substrate-2.

20 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling.

20 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Control of ceramide-induced apoptosis by IGF-1: involvement of PI-3 kinase, caspase-3 and catalase

20 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function

20 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

Differential roles of insulin receptor substrates in the anti-apoptotic function of insulin-like growth factor-1 and insulin

20 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

PTEN expression causes feedback upregulation of insulin receptor substrate 2

20 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.09.090

20 March 2024

Identifiers

1 reference

22 September 2017

1 reference